716 related articles for article (PubMed ID: 14528972)
1. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
2. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
3. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
Chan GH; Prestwich WV
Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
Hedtjärn H; Carlsson GA; Williamson JF
Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
6. On the development of consensus values of reference dosimetry parameters for interstitial brachytherapy sources.
Chan GH; Nath R; Williamson JF;
Med Phys; 2004 May; 31(5):1040-5. PubMed ID: 15191290
[TBL] [Abstract][Full Text] [Related]
7. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
Duggan DM
Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
9. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
Rivard MJ; Melhus CS; Kirk BL
Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric characteristic of a new 125I brachytherapy source.
Sadeghi M; Khanmohammadi Z
Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry of the 198Au source used in interstitial brachytherapy.
Dauffy LS; Braby LA; Berner BM
Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characteristics of a linear array of gamma or beta-emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism.
Ye SJ; Parsai EI; Feldmeier JJ
Med Phys; 2003 Mar; 30(3):403-14. PubMed ID: 12674241
[TBL] [Abstract][Full Text] [Related]
13. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
14. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dosimetry of 60Co HDR brachytherapy sources.
Papagiannis P; Angelopoulos A; Pantelis E; Sakelliou L; Karaiskos P; Shimizu Y
Med Phys; 2003 Apr; 30(4):712-21. PubMed ID: 12722823
[TBL] [Abstract][Full Text] [Related]
16. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
18. Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE 125I brachytherapy source.
Meigooni AS; Hayes JL; Zhang H; Sowards K
Med Phys; 2002 Sep; 29(9):2152-8. PubMed ID: 12349937
[TBL] [Abstract][Full Text] [Related]
19. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
[TBL] [Abstract][Full Text] [Related]
20. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.
Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D;
Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
